We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Therapeutic Delivery – Products

Gloved hand holding test tube near DNA helix, symbolizing gene therapy research.
Product News

Aptamer Announces New Data at ASGCT

Aptamer Group presented new data on its Optimer therapeutic delivery vehicle for liver fibrosis, showing its potential for broad applicability in fibrotic diseases at the ASGCT 2025 Annual Meeting.
Gloved hand holding three syringes, representing Optimer binders used as vaccine adjuvants.
Product News

Licensing Agreed for Optimer As Novel Vaccine Adjuvant

Aptamer licenses Optimers to the University of Glasgow for use in swine vaccines, targeting global animal health markets.
Scientist using a pipette to apply liquid to a petri dish in a drug delivery research lab.
Product News

Cyprumed Enters License and Option Agreement With MSD for the Development of Oral Peptide Therapeutics

Cyprumed and MSD have partnered to develop oral peptide formulations using Cyprumed’s drug delivery technology.
Scientist analyzing molecular imaging data on a computer screen in a modern drug discovery lab.
Product News

BOC Sciences Returns to Drug Discovery Chemistry 2025, Seeking Broad Partnerships

BOC Sciences adds to its participation agenda the prestigious Drug Discovery Chemistry 2025 Conference (April 14-17, 2025), which will be a hybrid event taking place in San Diego, CA, and will offer virtual access for worldwide attendees.
A scientist holding a vial containing a liquid with a DNA helix design, symbolizing the drug manufacturing process and biotechnology.
Product News

LGM Pharma Invests $6M in U.S. Drug Manufacturing Capabilities

LGM Pharma announces a $6M investment to expand its Rosenberg, Texas facility, enhancing its capacity for liquid, semi-solid and suppository drug production. The expansion supports growing prescription drug demand.
Three researchers working in a lab.
Product News

Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration With Thermo Fisher Scientific for Long-Acting Oral Therapies

Lyndra Therapeutics, a clinical-stage biopharmaceutical company, announced a strategic collaboration with Thermo Fisher Scientific Inc.
A researcher pipetting into a test tube.
Product News

ABITEC Unveils Comprehensive Custom Lipid Synthesis Capabilities for LNP Therapeutics

LNP developers now have access to bench-to-patient lipid synthesis support from a single partner.
Cells.
Product News

New Scientific Advisory Board Members

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, is pleased to announce three new members to its Scientific Advisory Board (SAB).
A vial containing invitrogen vivofectamine delivery solutions next to a box.
Product News

Thermo Fisher Scientific Introduces Invitrogen™ Vivofectamine™ Delivery Solutions To Help Advance Life Science Research and Genetic Medicines

Thermo Fisher Scientific has introduced the Invitrogen Vivofectamine™ Delivery Solutions to provide high-performance lipid nanoparticles (LNP) technology for non-viral delivery of nucleic acids.
Three researchers working in a lab.
Product News

Aptamer Extends Agreement With Genetic Medicines Customer

Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders, is pleased to announce that a genetic medicines customer has selected to progress to the final commercial development phase for Optimer delivery vehicles.
Advertisement